Familial Testotoxicosis
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Constitutive activity of the LHR causes LH releasing hormone-independent precocious puberty in boys and the autosomal dominant disorder familial male-limited precocious puberty (FMPP).
|
10704433 |
2000 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix.
|
11134146 |
2000 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Gonadotropin-independent precocious puberty due to luteinizing hormone receptor mutations in Brazilian boys: a novel constitutively activating mutation in the first transmembrane helix.
|
11134146 |
2000 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
In the present study, we analyzed the LH-R gene in members of a Japanese FMPP family.
|
11228053 |
2000 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
In boys with familial male-limited precocious puberty, an activating mutation of the luteinizing hormone receptor causes Leydig cell hyperplasia, resulting in excess testosterone production.
|
11391350 |
2001 |
Familial Testotoxicosis
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Together, these analyses suggest that exon 11 of human LHCGR could be more susceptible to mutation than the other 10 exons together and that activation of LHCGR, contingent to the somatic silencing of neighbouring ALF, could be linked to male-limited precocious puberty and pre-eclampsia.
|
16087288 |
2005 |
Familial Testotoxicosis
|
0.800 |
Biomarker
|
disease |
CTD_human |
Activating mutations in the luteinizing hormone receptor gene: a human model of non-follicle-stimulating hormone-dependent inhibin production and germ cell maturation.
|
16684832 |
2006 |
Familial Testotoxicosis
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
This report underscores the possibility that the effects of the mutant luteinizing hormone/choriogonadotropin receptor on phenotypic expression of FMPP, such as adult final height, are modified by other factors.
|
16887451 |
2006 |
Familial Testotoxicosis
|
0.800 |
Biomarker
|
disease |
CTD_human |
Update on the etiology, diagnosis and therapeutic management of sexual precocity.
|
18345393 |
2008 |
Familial Testotoxicosis
|
0.800 |
Biomarker
|
disease |
CTD_human |
Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
|
19209621 |
2008 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor.
|
20333877 |
2009 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Novel C617Y mutation in the 7th transmembrane segment of luteinizing hormone/choriogonadotropin receptor in a Japanese boy with peripheral precocious puberty.
|
21060208 |
2010 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
To generate a mouse model for the human disease, we have introduced an aspartic acid to glycine mutation in amino acid residue 582 (D582G) of the mouse LHR gene corresponding to the most common D578G mutation found in boys with familial male-limited precocious puberty (FMPP).
|
23861372 |
2013 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We report here two patients who presented with peripheral precocious puberty and an activating mutation in the LHCGR gene: one with a family history and previously determined mutation and the other without family history and with a novel mutation (c.830G>T).
|
26831561 |
2015 |
Familial Testotoxicosis
|
0.800 |
Biomarker
|
disease |
CTD_human |
We report here two patients who presented with peripheral precocious puberty and an activating mutation in the LHCGR gene: one with a family history and previously determined mutation and the other without family history and with a novel mutation (c.830G>T).
|
26831561 |
2015 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Activating mutations in LHCGR cause familial male-limited precocious puberty (FMPP).
|
28339861 |
2017 |
Familial Testotoxicosis
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Activating mutations in the luteinizing hormone receptor gene (LHCGR) cause high autonomous testosterone secretion, resulting in early-onset peripheral precocious puberty.
|
29029242 |
2017 |